Chaperon Inc. will begin offering a new service, "Shaperon Materials Review AI (beta version)," in April 2025. This service is a solution that uses AI to analyze table data, graphs, images, and text to automatically review promotional materials used by pharmaceutical companies. As regulations become stricter and promotion becomes more digital, pharmaceutical companies are facing the challenge of balancing stricter review and monitoring with the rapid dissemination of information. In particular, the increasing volume of digital content and materials, including figures, graphs, and images, requires a lot of manpower and time to review, which often becomes a bottleneck in the rapid dissemination of information. We have supported the efficiency of monitoring and reviewing text information through services such as "Monitoring AI". However, the following challenges remain in the review work…
Otsuka Shokai Co. Ltd. announced that it will start offering "Tayoreru EDR Advisory Service for…
Telexistence Inc. has joined the AI Robot Association as a board member and has begun…
In GovTech news this week… 🔹 Plus and TIER IV Partner to Advance Autonomy 2.0…
Amazon Web Services (AWS) has launched its new quantum computing chip, "Ocelot." This move puts…
GE HealthCare Technologies Inc. has bought the last 50% of Nihon Medi-Physics Co., Ltd. This is a big milestone. (NMP)…
Takeda Pharmaceutical Company Limited announced today that its Board of Directors unanimously resolved to appoint Julie Kim, currently President of…
Big M's Y Inc., a subsidiary of J-Stream Inc. , has formed a business alliance with the Association for Disseminating…
Pharmashift Inc. is pleased to announce that its "Tsunagari Pharmacy" has partnered with Clinic Fore Group ), which offers face-to-face…
FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery AI Factory Accelerating research and development of prescription…
NEC Corporation (hereinafter referred to as NEC) and biomy, Inc. (hereinafter referred to as biomy) have signed a memorandum of…
Sign in to your account